Search results
Found 294 matches for
Biotechnology company, Base Genomics, has launched based on Dr Chunxiao Song’s innovative TAPS technology.
The Suspected CANcer (SCAN) pathway
Accelerating diagnosis in people with non-specific symptoms of cancer
Lung cancer earlier diagnosis
The University of Oxford is leading two programmes of research focused on accelerating pathways for the earlier diagnosis of lung cancer. These programmes have received a total of >£12.5 million funding from UK Research and Innovation, the National Institute for Health Research, Cancer Research UK and industry.
DeLIVER: Early detection of hepatocellular liver cancer
This CRUK-funded programme led by Professor Ellie Barnes is characterising the pre-cancerous liver microenvironment and integrating multi-modal technologies to develop and refine strategies for translatable liver cancer risk prediction and early detection.
Epigenetic sequencing using TAPS
Drs Chunxiao Song and Benjamin Schuster-Böckler have developed a new, more sensitive detection method for methylated DNA with potential for use as a liquid biopsy test for cancer.